7-112461996-A-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001550.4(IFRD1):c.619-5A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00225 in 1,609,074 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001550.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IFRD1 | NM_001550.4 | c.619-5A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000403825.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IFRD1 | ENST00000403825.8 | c.619-5A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001550.4 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00153 AC: 233AN: 152086Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00268 AC: 672AN: 250596Hom.: 5 AF XY: 0.00334 AC XY: 452AN XY: 135450
GnomAD4 exome AF: 0.00232 AC: 3381AN: 1456870Hom.: 29 Cov.: 32 AF XY: 0.00270 AC XY: 1957AN XY: 725162
GnomAD4 genome AF: 0.00154 AC: 235AN: 152204Hom.: 4 Cov.: 32 AF XY: 0.00164 AC XY: 122AN XY: 74420
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at